Category Archives: Health Economics

More on Health Care Costs: The LA Experience

This, from the April 18 LA Times, describes the rather complicated dance some insurers go through before approving a procedure, and why we pay so much for care, even if we carry insurance.

Ted Kamp wanted to make sure his daughter received the medical treatment she needed. That was his first priority.

nHis second was making sure his insurance would cover things and that he’d pay a fair price for any procedures.

The fact that this proved so difficult highlights one of the crazier aspects of the U.S. healthcare system: the inability of patients to know how much their treatment really costs.

Cigna’s  preapproval procedure required an evaluation of the indication for the MRI by  a third party contractor.  In this case the insurer paid nothing for the procedure as the family had not yet paid their $5000/year deductible.  When approved, the patient was expected to accept whatever was charged by the “approved” provider, and not afforded the opportunity to shop for the best price. 

The price paid was several times the cost of other providers in the area and  multiples (my estimate) of the amount charged if the insurer was paying the bill directly—this patient has a $5000 deductible and the bill came to $4700. 

Medicynical Note:  We have the most expensive health care costs in the world, no one else is even close.  

Insurers get the best prices for care through their negotiating leverage.  The uninsured, or in this case those still paying off their deductible are charged more, multiple of the insurance payment.   This is a system designed to assure profits not quality affordable care. 

Prostate Cancer Radiation: Proton beam costs twice as much, twice as good? NO

A recent retrospective study looked at outcomes in prostate cancer treated with Proton radiotherapy (PRT)  vs intensity-modulated radiotherapy (IMRT).

And the results:

We identified 27,647 men; 553 (2%) received PRT and 27,094 (98%) received IMRT. Patients receiving PRT were younger, healthier, and from more affluent areas than patients receiving IMRT. Median Medicare reimbursement was $32,428 for PRT and $18,575 for IMRT. Although PRT was associated with a statistically significant reduction in genitourinary toxicity at 6 months compared with IMRT (5.9% vs 9.5%; odds ratio [OR] = 0.60, 95% confidence interval [CI] = 0.38 to 0.96, P = .03), at 12 months post-treatment there was no difference in genitourinary toxicity (18.8% vs 17.5%; OR = 1.08, 95% CI = 0.76 to 1.54, P = .66). There was no statistically significant difference in gastrointestinal or other toxicity at 6 months or 12 months post-treatment.

Medicynical Note:  There is a build it and they will come mentality in medicine that applies to new approaches that are costly and have little benefit.  In this case Proton Beam radiotherapy has a word of mouth that it is less “toxic”,  fostered in part by institutions that invested in this prohibitively expensive equipment. 

It appears, however, that the benefits of this modality are overstated, as often is the case with medical “advances,” and that the nearly 100% additional expense of proton beam treatment  is not justified in prostate cancer.

What’s Wrong with American Health Care: The Prices, Stupid

Ezra Kline has a post on prices for health services in the U.S. versus other industrialized countries.  His data is taken from a report from the International Federation of Health Plans.  Guess where it is more expensive…it’s not even close!

Medicynical Note:  It’s hard to believe that some die hard reactionaries think this is the best health care “system” in the world. 

America’s Exceptional Health Care Costs—We are Number 1

Brookings has an analysis of the impact of our uncontrolled health care costs:

By 2010 the U.S. health share was almost 7.2 percentage points of GDP (or 70 percent) higher than the health spending share in countries with comparable incomes. We can describe that estimate in a slightly different way: The United States spent about $7,500 per capita on health care compared to an average of $3,300 in other rich countries.

The article looks at income over the past 30 years including and omitting the cost of health benefits.  It notes that incomes have risen more than usual measures indicate when one includes the costs of health coverage for employees.

Medicynical Note:  The article notes that average income rose 35% in that time period while the cost of health benefits/capita rose 205% affecting the income increase when included in the calculation.  Of course we need a similar accounting of the increase in out of pocket medical expenditures to understand the full impact on disposable income.

It’s all about healthcare: “It’s” is the Economy Stupid

Read this

Medicynical Note:  This is where we find out if in a democracy we can control health care costs by choosing the most cost efficient approaches.  Markets won’t work.  The rub is the influence of the big moneyed lobbies of the Medical Industrial Complex….the game is on!

Why markets won’t work in health care was discussed 50 years ago by Kenneth Arrow and nothing seems to have disproven his contentions since them.  Read this for an introduction… and this for the original discussion. 

Health Reform (AKA Obamacare) Will Save Money AND Improve Care

Health care spending in the U.S. has been out of control for several decades.  It’s unsustainable and the two candidates for president have conflicting approaches.

The Romney/Ryan way is to ration care by cost.  If you don’t have the money you are out of luck, we might let you go to an ER.

The Obama administration’s reform, modeled ironically after the Massachusetts law which once was Romney’s great achievement, decreases spending by focusing on improved efficiency.  This Health Affairs piece highlights the approach to one of the most expensive patient care groups, the Medicare/Medicaid dual eligibles.

Here’s what ineffective care in our current non-system looks like:

Mary, like most of her counterparts, has never had a primary care relationship because primary care with the skills, intensity, and organization to meet her needs doesn’t exist. Instead Mary, like most of her peers, receives care from an array of specialists — in her case, Neurology, Pulmonary, Orthopedic, Gastrointestinal, and Endocrine specialists in three different non-communicating hospital systems — with no one capable of, or responsible for, providing the totality of her care. Thus Mary’s years of so-called “independent living” have been characterized by multiple recurrent hospitalizations for entirely predictable complications: pneumonia (in one case requiring a 14-month stay in a Medicaid-funded, post-acute respiratory rehabilitation hospital); poorly controlled diabetes; seizure management; and functional GI problems, with overall health, and functional decline.

These are the most expensive patients to care for and at present we do little to coordinate and anticipate their problems.

Massachusetts has instituted programs, many of which are in the President’s health care reform program to provide better, and it should be noted less expensive care to these patients.  An assessment of their approach showed:

  • According to a Lewin Associates study commissioned by the SNP Alliance, hospital admissions and days were 56 percent of the risk-adjusted Medicare dual-eligible FFS experience (2009 to 2011).
  • The NCQA risk-adjusted 30 day hospital readmission rate in 2010 was 4 percent compared with the median Medicare Advantage program rate of 13 percent (99th percentile).
  • The permanent nursing home placement rate for nursing home certifiable members between 2009 and 2011 was 34 percent of that seen in a Nursing Home Certifiable frail elder population in FFS care.
  • The seven year annual average total medical expense increase is 3.3 percent and 2.8 percent for nursing home certifiable and ambulatory, enrollees respectively, well below the Medicare trend.
  • CMS Quality Star Ratings of 4.5 Stars ranked in the 90th percentile of all Medicare Advantage Plans and the 99th percentile of all Medicare Advantage Special Needs Plans in 2010 and 2011.
  • Multiple evaluations of the younger disability care program over many years found a high degree of satisfaction, a 60 percent reduction in hospitalizations, and a 50 percent reduction in surgical flap procedures for pressure sores in a spinal cord injured subpopulation.

Medicynical Note:  The President’s health  reform not only assures health care coverage, but has the capability to encourage more efficient services.

The Romney approach, farms out coverage to private insurers.  His does not mandate use of community ratings to determine rates.  That means a private insurer could and would charge whatever they wanted to dissuade people from choosing their plan–they really, really don’t want sick people in their covered patient pool.  Furthermore, with the dismantling of Medicare and to a great extent Medicaid that Romney envisions there would be no pressure to develop better, more efficient care for these patients.  

This election is crucial for health care in the U.S. and more than a choice of insurers is at stake.  In the end I suppose we’ll get what we deserve!

 

Cost Matters: Colon Cancer, Zaltrap (ziv-afibercept)

Sounds crazy, a drug (Zaltrap) costing $11,000/month, with little efficacy is being actively promoted to desperate patients.  A classic case of any promise of efficacy, no matter how small, or how expensive, being irresistible to those with dread diseases. 

What’s even more amazing this article makes the righteous argument that another drug costing only (sic) $5000/month (Avastin)  offering similar (in-)efficacy should be used in it’s stead. 

The “benefit” of these super expensive drugs is roughly the same,  a miniscule 1.4 months median survival.

Medicynical Note:  It’s good that Sloan Kettering finally seems to recognize the folly of a minimally effective agent costing so much.  The benefits, by the way,  are truly minimal.  When a drug offers a median benefit of 1.4 months it means that half the people got less than that benefit (at $11,000/month).  True, half did better but the same could be said of the conventional regimen or placebo with which it’s compared. 

Does 1.4 months median benefit justify the expenditure of over $60,000/year (more than the median or average income of families in our country) on a single drug?  And this expense doesn’t include doctor’s fees, lab costs or imaging expenses. 

Our Non-System of Health Care — Escape Fire, the documentary

Escape Fire is a film documentary that is about to be released that looks at our non-system of health care.  The preview is here, and while I can’t say  that I agree with everything in it, it appears to have the diagnosis correct.  We have a medical industrial complex whose goal is to make money rather than provide care.  That’s a big problem.

The Emperor’s Clothes–U.S. vs Canada Health Care

The following links  compare our non-system of health care with the national health program of Canada.

It’s a stark contrast and  explains why so many American are forced into bankruptcy by health care expenses.

This talks a bit about the costs of having a baby in the U.S.  even if you have “good” insurance–several thousand dollars.

As opposed to Canada where the total medical cost of childbearing appears to be  $25.  The interviews in this article also highlight the satisfaction of Canadians with their system of health care.

 

Failing Those With the Most Need: Life Expectancy Decreases

What do you say to a health care non-system that’s going backwards?  Reform!

For the first time in several generations there has been a decrease in life expectancy in the U.S.

Four studies in recent years identified modest declines, but a new one that looks separately at Americans lacking a high school diploma found disturbingly sharp drops in life expectancy for whites in this group. Experts not involved in the new research said its findings were persuasive.

The reasons for the decline remain unclear, but researchers offered possible explanations, including a spike in prescription drug overdoses among young whites, higher rates of smoking among less educated white women, rising obesity, and a steady increase in the number of the least educated Americans who lack health insurance.

Medicynical Note:  It’s becoming irrefutable.  We lead the industrialized world in decreases in longevity.  The only question I have is whether current health reform will do enough to reverse the trend.

To repeat the mantra, we pay more per capita and get poorer outcomes than any other health care system in the industrialized world (I know of no other country with declining longevity).  We have nearly 50 million people without easy access to care (health insurance and all that goes with it) and we do lead the industrialized world in bankruptcies due to medical expenses–it’s unknown elsewhere.  We are truly numero uno.